EU drug safety surveillance project eyes code of conduct adoption date
This article was originally published in Scrip
The steering group of European Medicines Agency-led pharmacoepidemiology and pharmacovigilance project, the ENCePP, is expected to finalise and adopt a code of conduct in the second quarter of 2010, it was revealed at the Drug Information Association's 22nd Annual EuroMeeting in Monaco on 8-10 March.
You may also be interested in...
Now that the European Medicines Agency has finalized its formal safety review procedure into Xeljanz, Pfizer is telling health care professionals what precautions they must take when prescribing the drug.
Health technology assessment body NICE is consulting on draft guidance that recommends Axonics' device for overactive bladder.